SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine

Signal Transduct Target Ther. 2022 Jul 5;7(1):211. doi: 10.1038/s41392-022-01088-7.
No abstract available

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Pandemics / prevention & control
  • SARS-CoV-2
  • Viral Vaccines*

Substances

  • Viral Vaccines